Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS23P6 (Ribosomal protein S23 pseudogene 6) is a processed pseudogene in the human genome related to the protein-coding gene RPS23, which encodes a structural constituent of the small ribosomal 40S subunit involved in protein synthesis[2][4]. Unlike RPS23, the RPS23P6 pseudogene does not encode a functional protein and has no known biological function, disease associations, or therapeutic relevance[2][4]. This pseudogene is one of several dispersed through the genome, a common feature for ribosomal protein genes[1][4]. No variant or expression information is available for RPS23P6, and it is not considered a canonical molecular target in biomedical research or drug development[2][4].
None (no known mechanism of action; not a protein target).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S23 pseudogene 6 (RPS23P6).